Metagenomi Therapeutics, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene editing toolbox, therapeutic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
202
Frequently Asked Questions
What is Market Cap of Metagenomi Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Metagenomi Therapeutics Inc. market cap is $59.32M.
What is the 52-week high for Metagenomi Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Metagenomi Therapeutics Inc. 52 week high is $3.95 as of January 31, 2026.
What is the 52-week low for Metagenomi Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Metagenomi Therapeutics Inc. 52 week low is $1.23 as of January 31, 2026.
What is Metagenomi Therapeutics Inc. stock price today?
Metagenomi Therapeutics Inc. stock price today is $1.54.
What was Metagenomi Therapeutics Inc. stock price yesterday?
Metagenomi Therapeutics Inc. stock price yesterday was $1.58.
What is the PE ratio of Metagenomi Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Metagenomi Therapeutics Inc.’s P/E ratio is -0.65.
What is the Price-to-Book ratio of Metagenomi Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Metagenomi Therapeutics Inc. P/B ratio is 0.324.
What is the 50-day moving average of Metagenomi Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Metagenomi Therapeutics Inc. 50-day moving average is $1.68.
How many employess does Metagenomi Therapeutics Inc. has?